# Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis

> **NCT04858009** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 40 (estimated)

## Conditions studied

- Metastatic Pancreatic Carcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Metastatic Malignant Neoplasm in the Peritoneum

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Hyperthermic Intraperitoneal Chemotherapy
- **DRUG:** Nab-paclitaxel
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT04858009
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-15
- **Primary completion:** 2029-07
- **Final completion:** 2029-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04858009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04858009, "Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04858009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*